Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Management of adverse events d ...... sed treatment in breast cancer
@en
Management of adverse events during cyclin-dependent kinase 4/6
@nl
type
label
Management of adverse events d ...... sed treatment in breast cancer
@en
Management of adverse events during cyclin-dependent kinase 4/6
@nl
prefLabel
Management of adverse events d ...... sed treatment in breast cancer
@en
Management of adverse events during cyclin-dependent kinase 4/6
@nl
P2860
P356
P1476
Management of adverse events d ...... sed treatment in breast cancer
@en
P2093
Marc Thill
Marcus Schmidt
P2507
P2860
P304
1758835918793326
P356
10.1177/1758835918793326
P407
P577
2018-01-01T00:00:00Z